Abstract
The loss of heterologous protein expression is one of the major problems faced by industrial cell line developers and has been reported by several authors. Therefore, the understanding of the mechanisms involved in the generation of stable and high producer cell lines is a critical issue, especially for those processes based on long term continuous cultures. We characterized two recombinant NS0 myeloma cell lines expressing Nimotuzumab, a humanized anti-human epidermal growth factor receptor (EGFR) antibody. The hR3/H7 clone is a stable producer obtained from the unstable hR3/t16 clone. The unstable clone was characterized by a bimodal distribution of intracellular immunoglobulin staining using flow cytometry. Loss of antibody production was due to the emergence of a non-producer cell subpopulation that increased with cell generation number. Immunoglobulin heavy chain (HC) and light chain (LC) ratio (HC/LC) was lower for the unstable phenotype. Proteomic maps using two dimensional gel electrophoresis (2DE) were obtained for both clones, at initial cell culture time and after 40 generations. Fifteen proteins potentially associated with the phenomenon of production stability were identified. The hR3/H7 stable clone showed an up-regulated expression pattern for most of these proteins. The regulation of recombinant antibody production by the host NS0 myeloma cell line most likely involves simultaneously cellular processes such as DNA transcription, mRNA processing, protein synthesis and folding, vesicular transport, glycolysis and energy production, according to the proteins identified in the present proteomic study.
Similar content being viewed by others
References
Agshe VR, Hartl F-U (2000) Roles of molecular chaperones in cytoplasmic protein folding. Cell Dev Biol 11:15–25
Alete D, Racher AJ, Birch JR, Stansfield SH, James D, Smales CM (2005) Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Proteomics 5:4689–4704
Barnes L, Dickson A (2006) Mammalian cell factories for efficient and stable protein expression. Curr Opin Biotechnol 17:381–386
Barnes L, Bentley C, Dickson A (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109–123
Barnes L, Bentley CM, Dickson A (2003) Stability of protein production from recombinant mammalian cells. Biotechnol Bioeng 81:631–639
Barnes L, Bentley C, Dickson A (2004) Molecular definition of predictive indicators of stable protein expression in recombinant NS0 myeloma cells. Biotechnol Bioeng 85:115–121
Barnes L, Bentley CM, Moy N, Dickson AJ (2007) Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells. Biotechnol Bioeng 96:337–348
Castillo A, Victores S, Faife E, Rabasa Y, de la Luz KR (2005) Development of an integrated strategy for recombinant cell line selection. In: Gódia F, Fussenegger M (ed) Animal cell technology meets genomics. Springer, Berlin, pp 505–507
Chevalier S, MacDonald N, Tonge R, Rayner S, Rowlinson R, Shaw J, Young J, Davison M, Roberts R (2000) Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferators nafenopin. Eur J Biochem 267:4624–4634
de la Luz KR, Rojas L, Victores S, Lage A, Eyers C, Hart S, Castellanos L, Castillo A, Gaskell S (2008) Proteomic analysis of the adaptation of the host NS0 myeloma cell line to a protein-free medium. Biotecnología Aplicada 24:215–223
Dinnis D, James D (2005) Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature? Biotechnol Bioeng 91:180–189
Dorai H, Csirke B, Scallon B, Ganguly S (2006) Correlation of heavy and light chain mRNA copy numbers to antibody productivity in mouse myeloma production cell lines. Hybridoma 25:1–9
Faife E, Rodríguez T, Rabaza Y, Badía T, Victores S, Castillo A (2008) Effects of selection and adaptation of NS0 cells to protein-free medium on the properties, affinity and biological activity of a monoclonal antibody. Biotecnología Aplicada 25:247–253
Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM (1999) Mass spectrometric identification of proteins from silver-stained polyacrylamide gels: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601–605
Hutchison S, LeBel C, Blanchette M, Chabot B (2002) Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5′ splice site selection in the hnRNP A1 mRNA precursor. J Biol Chem 277:29745–29752
Köhler G, Milstein C (1976) Derivation of specific antibody-producing tissue culture and tumour lines by cell fusion. Eur J Inmunol 6:511–519
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
MacIver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC (2008) Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84:949–957
Martínez A, Mulshine JL (2002) Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) as a marker of preinvasive lung cancer. J Clin Ligand Assay 25:100–103
Mateo C, Moreno E, Amour K, Lombardero J, Harris W, Pérez R (1997) Humanization of mouse monoclonal antibody that block the EGF-R: recovery of antagonistic activity. Immunotechnology 3:71–81
Nasim FU, Hutchison S, Cordeau M, Chabot B (2002) High-affinity hnRNP A1-binding sites and duplex–forming inverted repeats have similar effects on 5′ splice site selection in support of a common looping out and repression model. RNA 8:1078–1089
Nogales E, Wolf SG, Downing KH (1998) Structure of the alpha beta tubulin dimer by electron crystallography. Nature 391:199–203
Ou XM, Chen K, Shih JC (2006) Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci USA 103:10923–10928
Piskunova TS, Yurova MN, Ovsyannikov AI, Semenchenko AV, Zabezhinski MA, Popovich IG, Wang ZQ, Anisimov VN (2008) Deficiency in poly (ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice. Curr Gerontol Geriatr Res 754190. Epub Apr 14. PMID: 19415146
Rojas LE, de la Luz KR, Victores S, Castellanos L, Gaskell S, Castillo A, Pérez R (2005) Comparative proteomic study of mechanisms involved in the expression of recombinant monoclonal antibody in non amplified NS0 myeloma cell line. In: Smith R (ed) Cell technology for cell products. Springer Publisher, Berlin, pp 715–721
Schlatter S, Stansfield S, Dinnis DM, Racher A, Birch J, James D (2005) On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol Prog 21:122–133
Seth G, Philp RJ, Lau A, Jiun KY, Yap M, Hu WS (2007) Molecular portrait of high productivity in recombinant NS0 cells. Biotechnol Bioeng 97(4):933–951
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–858
Smales CM, Dinnis DM, Stansfield SH, Alete D, Sage EA, Birch JR, Racher AJ, Marshall CT, James DC (2004) Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol Bioeng 88:474–488
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Voet D, Voet JG (1995) Translation. In: Rose N (ed) Biochemistry, second edition. Wiley, New York, pp 997–1003
Wallrath LL (1998) Unfolding the mysteries of heterochromatin. Curr Opin Genet Dev 8:147–153
Whitford W (2003) NS0 serum-free culture and applications. BioProcess Int 12:36–47
Wilson C, Bellen HJ, Gehring WJ (1990) Position effects on eukaryotic gene expression. Annu Rev Cell Biol 6:679–714
Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cell. Nat Biotechnol 22:1393–1398
Acknowledgments
We thank Dr. Yassel Ramos Gómez from the Center of Genetic Engineering and Biotechnology (CIGB, Havana, Cuba) for his valuable help in the proteomics assays and Dr. Alejandro López-Requena for a careful reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
10616_2011_9348_MOESM1_ESM.tif
Supplementary figure 1 . Immunoblot analysis of hR3 antibody chains. HC and LC polypeptides from purified hR3 antibody were detected using an alkaline phosphatase-conjugated anti-human γ-chain antibody or a horseradish peroxidase-conjugated goat anti-human ĸ chain antibody, respectively. (TIFF 166 kb)
Rights and permissions
About this article
Cite this article
Prieto, Y., Rojas, L., Hinojosa, L. et al. Towards the molecular characterization of the stable producer phenotype of recombinant antibody-producing NS0 myeloma cells. Cytotechnology 63, 351–362 (2011). https://doi.org/10.1007/s10616-011-9348-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-011-9348-7